* USANA Health Sciences Inc USNA.N USNA.K is expected
to show
a fall in quarterly revenue when it reports results on July
25.
* The Salt Lake City Utah-based company is expected to
report a
12.6% decrease in revenue to $231.144 million from $264.47
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for USANA Health
Sciences Inc
is for earnings of 70 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for USANA
Health
Sciences Inc is $64, above its last closing price of $63.07.
This summary was machine generated July 22 at 02:01 GMT. All
figures in US dollars unless otherwise stated